|
|
|
|
|
Feature Press Release from DailyUpdates
|
FDA Accepts IND Application For Sativex
LONDON, Jan. 3 - GW Pharmaceuticals today announced that the FDA has accepted its IND Application for Sativex, a cannabis- derived, oro-mucosal spray composed primarily of tetrahydrocannabinol and cannabidiol, a non-psychoactive cannabinoid, for the treatment of pain in patients with advanced cancer that has not been adequately relieved by opioid medications....more
For further information on this field see Cannabinoids - A potential blockbuster market
Entry date Wednesday, January 04, 2006
Editorial Comment
About DailyUpdates: DailyUpdates is an e-mail bulletin service launched in 2002 by the pharmaceutical analysts LeadDiscovery. The service represents the first "newsfeed" that identifies breaking scientific journal articles selected by LeadDiscovery's industrial panel for their drug development potential as well as press releases on clinical trial data and regulatory affairs announcements. Click here to learn more about DailyUpdates
Important notes
This content has been produced by LeadDiscovery Ltd. Founded by life scientists for life scientists we aim to help industry identify cutting edge drug discovery options and academic/biotech institutions maximize the potential of their research. Visit our website for more details. Abstracts strictly reflect the opinion of LeadDiscovery's editorial panel. While all reasonable efforts are made to ensure the accuracy of information provided LeadDiscovery takes no responsibility for incorrect or misleading information. LeadDiscovery is designed for educational and drug development purposes only and is not intended or designed to offer medical advice or advice of any sort, and must not be used for such purpose. The information provided through LeadDiscovery should not be used for diagnosing or treating a health problem or a disease and no reliance should be placed on any information contained in this abstract or elsewhere on LeadDiscovery's website. It is not intended to be a substitute for professional care. If you have or suspect you may have a health problem, you should consult your physician or other health care provider
|